Jacqueline Racener was diagnosed with leukemia and prescribed a drug offering the hope of combating the cancer with only moderate side effects. However, upon learning that the annual cost would be $8,000, even with her Medicare insurance, Jacqueline opted to stop filling her prescription, hoping that the cancer would not progress further. With cancer drugs […]
A New Era: Key Implications of the Inflation Reduction Act on the Healthcare and Biopharma Ecosystem
February 6, 2024
Beyond Antibody Therapies: Novel Therapeutic Approaches to Combat Alzheimer’s Disease
February 6, 2024
Alzheimer’s disease (AD) is a neurological disorder that affects nearly 6.7 million Americans over the age of 65. The widespread nature of this disease means that many people are impacted by it in some way, whether it is being diagnosed with the disorder, or caring for an afflicted friend or family member. Despite its high […]
There’s an app for that: Digital Therapeutics
June 22, 2023
Sometimes a medical condition can be cured with a single surgery or a course of medications. But many illnesses — like diabetes, asthma, and chronic pain — require long-term treatment and management. Recognizing the assistive potential of smart phones and other personal computing devices, some doctors have begun recommending apps to help patients track their […]
Is Alcohol Use Disorder virtually solved?
May 11, 2023
Alcohol use is common in the United States. The vast majority of adults (84.0%) have drunk alcohol at some point in their lifetime, with most of them (79.5%) reporting having a drink in the last year. Many social events rely on the presence of alcohol, and most attend these events without alcohol disrupting their lives. […]
Ultra-rare genetic diseases: emerging strategies and new challenges
December 17, 2022
Genetic diseases, like cystic fibrosis and sickle cell disease, can be devastating to the people afflicted by them, but they often affect few people. The exact cutoffs vary from nation to nation, but in the United States, a rare disease is defined as one that afflicts fewer than 200,000 Americans. Most of these diseases are […]
Augmented Reality in spine surgery: a promising market niche with an uncertain business future
December 17, 2022
Imagine you are driving to a friend’s house. You have been there a few times and have formed some general impressions of the route. In the old days, you would only have your imperfect memory to guide you. Now you can use GPS not only to navigate the route, but also to see live traffic […]
Harvesting our gut communities to treat disease
December 12, 2022
A look at fecal microbiota transplants in universities and biotech companies Trillions of bacteria, along with some fungi, viruses, and archaea, make up our gut microbiome. These bacteria greatly outnumber our own cells and play a crucial role in our bodies. Researchers are exploring gut microbiome interventions to improve human health. In the last several […]
Promoting innovation in academia: from universities to startups and beyond
August 25, 2022
With both industry and the academic community working together, innovative ideas generated at universities could potentially lead to more successful startups and a better workforce.
The fight against the silent pandemic: a synergistic effort for combating antimicrobial resistance
May 23, 2022
The world is running out of weapons to fight against the threat of superbugs. A collective effort from healthcare, government, and industry is needed.
Lessons from microbial growing pains
December 22, 2021
While our society has grown accustomed to microbe-produced medicines like penicillin and insulin, biotechnology startups today, especially those in the San Francisco Bay Area, are increasingly looking to use these microscopic chemists in industries beyond pharmaceuticals.